Bank of America’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.5B Buy
11,274,243
+148,411
+1% +$152M 0.87% 17
2026
Q1
$10.2B Buy
11,125,832
+20,246
+0.2% +$20.5M 0.75% 22
2025
Q4
$11.9B Sell
11,105,586
-355,958
-3% -$340M 0.87% 18
2025
Q3
$8.75B Buy
11,461,544
+198,378
+2% +$148M 0.59% 26
2025
Q2
$8.78B Buy
11,263,166
+250,351
+2% +$195M 0.64% 23
2025
Q1
$9.1B Buy
11,012,815
+1,001,193
+10% +$833M 0.73% 21
2024
Q4
$7.73B Sell
10,011,622
-149,325
-1% -$124M 0.65% 23
2024
Q3
$9B Sell
10,160,947
-621,975
-6% -$559M 0.72% 22
2024
Q2
$9.76B Buy
10,782,922
+213,115
+2% +$170M 0.86% 15
2024
Q1
$8.22B Buy
10,569,807
+686,210
+7% +$488M 0.75% 19
2023
Q4
$5.76B Buy
9,883,597
+45,642
+0.5% +$26.6M 0.58% 27
2023
Q3
$5.28B Sell
9,837,955
-374,462
-4% -$193M 0.58% 32
2023
Q2
$4.79B Buy
10,212,417
+632,869
+7% +$265M 0.5% 32
2023
Q1
$3.29B Buy
9,579,548
+112,474
+1% +$37.9M 0.34% 62
2022
Q4
$3.46B Buy
9,467,074
+67,250
+0.7% +$23.8M 0.39% 49
2022
Q3
$3.04B Sell
9,399,824
-357,202
-4% -$113M 0.36% 51
2022
Q2
$3.16B Buy
9,757,026
+474,185
+5% +$142M 0.36% 56
2022
Q1
$2.66B Sell
9,282,841
-204,650
-2% -$52.7M 0.26% 82
2021
Q4
$2.62B Buy
9,487,491
+168,911
+2% +$42.8M 0.25% 89
2021
Q3
$2.15B Sell
9,318,580
-590,510
-6% -$146M 0.22% 98
2021
Q2
$2.27B Sell
9,909,090
-484,509
-5% -$97.3M 0.24% 89
2021
Q1
$1.94B Sell
10,393,599
-535,705
-5% -$105M 0.22% 101
2020
Q4
$1.85B Sell
10,929,304
-1,038,345
-9% -$155M 0.24% 105
2020
Q3
$1.77B Buy
11,967,649
+296,096
+3% +$45.8M 0.24% 101
2020
Q2
$1.92B Buy
11,671,553
+526,903
+5% +$80.9M 0.29% 80
2020
Q1
$1.55B Buy
11,144,650
+3,021,328
+37% +$415M 0.28% 94
2019
Q4
$1.07B Buy
8,123,322
+40,813
+0.5% +$4.73M 0.15% 148
2019
Q3
$904M Buy
8,082,509
+105,053
+1% +$11.7M 0.13% 162
2019
Q2
$884M Sell
7,977,456
-2,547,711
-24% -$300M 0.13% 164
2019
Q1
$1.37B Buy
10,525,167
+2,161,764
+26% +$263M 0.21% 113
2018
Q4
$968M Buy
8,363,403
+416,849
+5% +$46.6M 0.17% 144
2018
Q3
$853M Buy
7,946,554
+666,894
+9% +$66.7M 0.13% 163
2018
Q2
$621M Buy
7,279,660
+28,868
+0.4% +$2.37M 0.1% 207
2018
Q1
$561M Sell
7,250,792
-4,761,592
-40% -$383M 0.1% 218
2017
Q4
$1.01B Sell
12,012,384
-3,841,535
-24% -$327M 0.17% 139
2017
Q3
$1.36B Buy
15,853,919
+2,851,464
+22% +$234M 0.22% 118
2017
Q2
$1.07B Sell
13,002,455
-1,463,887
-10% -$119M 0.21% 119
2017
Q1
$1.22B Buy
14,466,342
+602,303
+4% +$48.2M 0.24% 103
2016
Q4
$1.02B Sell
13,864,039
-649,149
-4% -$48.3M 0.22% 110
2016
Q3
$1.16B Buy
14,513,188
+171,496
+1% +$13.7M 0.26% 93
2016
Q2
$1.13B Buy
14,341,692
+867,237
+6% +$65.3M 0.26% 96
2016
Q1
$970M Sell
13,474,455
-5,366,038
-28% -$406M 0.24% 102
2015
Q4
$1.59B Buy
18,840,493
+2,104,307
+13% +$175M 0.38% 55
2015
Q3
$1.4B Buy
16,736,186
+8,102,046
+94% +$684M 0.35% 59
2015
Q2
$721M Buy
8,634,140
+45,825
+0.5% +$3.49M 0.23% 86
2015
Q1
$624M Buy
8,588,315
+2,889,010
+51% +$206M 0.21% 111
2014
Q4
$393M Sell
5,699,305
-4,222,693
-43% -$285M 0.14% 156
2014
Q3
$643M Sell
9,921,998
-318,072
-3% -$20.1M 0.21% 100
2014
Q2
$637M Buy
10,240,070
+3,434,520
+50% +$205M 0.2% 105
2014
Q1
$401M Sell
6,805,550
-69,367
-1% -$3.87M 0.15% 154
2013
Q4
$351M Sell
6,874,917
-187,538
-3% -$9.39M 0.13% 181
2013
Q3
$355M Buy
7,062,455
+509,523
+8% +$26.7M 0.14% 151
2013
Q2
$322M Buy
+6,552,932
New +$357M 0.14% 151

Other funds holding LLY

Bank of America's LLY Position: Q2 2026 in Review

Bank of America increased its Eli Lilly (LLY) stake by 1.3% in Q2 2026, buying an estimated $152M and bringing the position to 11,274,243 shares worth $13.5B. The position accounts for 0.87% of the portfolio, ranked #17.

Bank of America first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Bank of America held 11,274,243 shares of Eli Lilly worth $13.5B as of Q2 2026.
  • Bank of America bought 148,411 Eli Lilly shares in Q2 2026, an estimated $152M.
  • Eli Lilly made up 0.87% of Bank of America's portfolio in Q2 2026, its #17 holding.
  • Bank of America first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.